For the first time in December 2019, a case of pneumonia of unknown etiology was reported in Wuhan, China. Then, in addition to China and on the basis of increasing incidence and mortality rates in other international countries, the global emergency health status was declared by the World Health Organization Emergency Committee, and a new coronavirus was reported.Due to the very high contagion rate of the new Coronavirus (COVID-19), it has affected and continues to affect quite a lot of people from all age groups in the world. General clinical signs of COVID-19 are high fever, cough, nasal congestion, dyspnea, myalgia, fatigue, upper and lower respiratory tract infection and diarrhea. The most important and fatal clinical sign of the virus has been described as pneumonia. Unfortunately, no vaccine or special antiviral drug has been developed against COVID-19 yet. Therefore, the purpose of this review is to examine whether intravenous vitamin C administration is a promising method for the COVID-19 pandemic in accordance with the most recent evidence. Using vitamin C to prevent or treat diseases is often classified in complementary and alternative medicine. For this reason, it should never prevent the actual treatment. Studies have found that high doses of vitamin C reduce lung damage in COVID-19 and other flu infections. Therefore, intravenous vitamin C administration may be useful in addition to COVID-19 treatment.There is a need for high-level clinical studies on the effect of Vitamin C administration on COVID-19.
Keywords: COVID-19; 2019-nCoV; the pandemic; vitamin C; pneumonia; acut respiratory distress syndrome
İlk kez, 2019 yılı aralık ayında, Çin'in Wuhan şehrinde, etiyolojisi bilinmeyen bir pnömoni vakası bildirilmiştir. Daha sonra Çin'e ek olarak ve diğer uluslararası ülkelerde artan vaka ve ölüm oranlarına dayanarak, Dünya Sağlık Örgütü Acil Durum Komitesi tarafından, küresel acil sağlık durumu ilan edilmiş ve bu duruma yeni bir koronavirüsün neden olduğu bildirilmiştir. Yeni Koronavirüsün (COVID-19) bulaşıcılık hızının çok yüksek olması nedeni ile dünya üzerinde her yaş grubundan oldukça fazla insanı etkilemiş ve etkilemeye devam etmektedir. COVID-19'un genel klinik belirtileri yüksek ateş, öksürük, burun tıkanıklığı, dispne, miyalji, yorgunluk, üst-alt solunum yolu infeksiyonu ve diyaredir. Virüsün en önemli ve ölümcül seyreden klinik belirtisi ise, pnömoni olarak tanımlanmıştır. Ne yazık ki COVID-19'a karşı henüz herhangi bir aşı veya özel antiviral bir ilaç geliştirilmemiştir. Bu nedenle bu derlemenin amacı en güncel kanıtlar doğrultusunda intravenöz vitamin C uygulamasının COVID-19 pandemisi için umut verici bir yöntem olup olmadığının irdelenmesidir. Hastalıkları önlemek veya tedavi etmek için vitamin C kullanımı genellikle tamamlayıcı ve alternatif tıp olarak sınıflandırılmaktadır. Bu nedenle asla asıl tedavinin önüne geçmemelidir. Yapılan çalışmalarda COVID-19 ve diğer gribal enfeksiyonlarda yüksek doz vitamin C akciğer hasarını azalttığı bulunmuştur. Bu nedenle COVID-19 tedavisine ek olarak intravenöz vitamin C uygulaması yararlı olabilir.Vitamin C uygulamasının COVID-19 üzerindeki etkisine yönelik kanıt düzeyi yüksek klinik çalışmalara gereksinim vardır.
Anahtar Kelimeler: COVID-19; 2019-nCoV; pandemik; vitamin C; pnömoni; akut respiratuar distres sendromu
- Velavan TP, Meyer CG. The COVID-19 epidemic. Trop Med Int Health. 2020;25(3):278-80. [Crossref] [PubMed] [PMC]
- Lake MA. What we know so far: COVID-19 current clinical knowledge and research. Clin Med (Lond). 2020;20(2):124-7. [Crossref] [PubMed] [PMC]
- Tyrrell DA, Bynoe ML. Cultivation of viruses from a high proportion of patients with colds. Lancet. 1966;1(7428):76-7. [Crossref]
- Hatipoğlu N. The "new" problem of humanity: new coronavirus (2019-nCoV/COVID-19) disease. Med J Bakirkoy. 2020;16(1):1-8. [Crossref]
- Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507-13. [Crossref]
- Carr AC, Maggini S. Vitamin C and immune function. Nutrients. 2017;9(11):1211-36. [Crossref] [PubMed] [PMC]
- Güleşci N, Aygül İ. [Located in antioxidant nutrition and phenolic subtances containing cookies]. Gümüşhane Üniversitesi Sağlık Bilimleri Dergisi. 2016;5(1):109-29.
- Cai Y, Li YF, Tang LP, Tsoi B, Chen M, Chen H, et al. A newmechanism of vitamin C effects on A/FM/1/47 (H1N1) virus-induced pneumonia in restraint-stress edmice. Biomed Res Int. 2015;2015:675149. [Crossref] [PubMed] [PMC]
- Koshiba T, Yasukawa K, Yanagi Y, Kawabata SI. Mitochondrial membrane potential is required for MAVS-mediated antiviral signaling. Sci Signal. 2011;4(158):ra7. [Crossref] [PubMed]
- Kim H, Jang M, Kim Y, Choi J, Jeon J, Kim J, et al. Red ginseng and vitamin C increase immune cell activity and decrease lung inflammation induced by influenza A virus/H1N1 infection. J Pharm Pharmacol. 2016;68(3):406-20. [Crossref] [PubMed]
- Stanislavovich Rogovskii V. The link age between inflammation and immune tolerance: interfering with inflammation in cancer. Curr Cancer Drug Targets. 2017;17(4):325-32. [Crossref] [PubMed]
- Hemilä H, Chalker E. Vitamin C can shorten the length of stay in the ICU: a meta-analysis. Nutrients. 2019;11(4):708. [Crossref] [PubMed] [PMC]
- Thosar SS, Bielko SL, Wiggins CC, Klaunig JE, Mather KJ, Wallace JP. Antioxidant vitamin C prevents decline in endothelial function during sitting. Med Sci Monit. 2015;21:1015-21. [Crossref] [PubMed] [PMC]
- Juraschek SP, Guallar E, Appel LJ, Miller ER 3rd. Effects of vitamin C supplementation on blood pressure: a meta-analysis of randomized controlled trials. Am J Clin Nutr. 2012;95(5):1079-88. [Crossref] [PubMed] [PMC]
- Ashor AW, Werner AD, Lara J, Willis ND, Mathers JC, Siervo M. Effects of vitamin C supplementation on glycaemic control: a systematic review and meta-analysis of randomised controlled trials. Eur J Clin Nutr. 2017;71(12):1371-80. [Crossref] [PubMed]
- Carr AC, Mc Call C. The role of vitamin C in the treatment of pain: new in sights. J Transl Med. 2017;15(1):77-91. [Crossref] [PubMed] [PMC]
- Ritzel G. [Critical evaluation of vitamin C as a prophylacticandtherapeuticagent in colds]. Helv Med Acta. 1961;28:63-8.
- Hunt C, Chakravorty NK, Annan G, Habibzadeh N, Schorah CJ. The clinical effects of vitamin C supplementation in elderly hospitalised patients with acute respiratory infections. Int J Vitam Nutr Res. 1994;64(3):212-9.
- Hemilä H, Louhiala P. Vitamin C for preventing and treating pneumonia. Cochrane Database Syst Rev. 2013;8(8):CD005532. [Crossref]
- Nathens AB, Neff MJ, Jurkovich GJ, Klotz P, Farver K, Ruzinski JT, et al. Randomized, prospectivetrial of antioxidant supplementation in critically ill surgical patients. Ann Surg. 2002;236(6):814-22. [Crossref] [PubMed] [PMC]
- Fowler AA, Syed AA, Knowlson S, Sculthorpe R, Farthing D, De Wilde C, et al. Phase I safety trial of intravenous ascorbic acid in patients with severe sepsis. J Transl Med. 2014;12(1):32-42. [Crossref] [PubMed] [PMC]
- Short KR, Kroeze EJ, Fouchier RA, Kuiken T. Pathogenesis of influenza-induced acute respiratory distress syndrome. Lancet Infect Dis. 2014;14(1):57-69. [Crossref]
- Fowler AA, Kim C, Lepler L, Malhotra R, Debesa O, Natarajan R, et al. Intravenous vitamin C as adjunctive therapy for enterovirus/rhinovirus induced acute respiratory distress syndrome. World J Crit Care Med. 2017;6(1):85-90. [Crossref] [PubMed] [PMC]
- https://mp.weixin.qq.com/s/bF2YhJKiOfe1yimBc4XwOA.
.: İşlem Listesi